Tip : |
časopis |
internet povezava : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=284 |
|
raziskovalne skupine : |
Houston - M.D.Anderson Cancer Center |
Avtor : |
Zhang YP, Trissel LA, Fox JL. |
Naslov : |
Naratriptan hydrochloride in extemporaneously compounded oral suspensions. |
Référence : |
Int J Pharm Compound ; 4: 69-71. 2000 |
|
Raven dokazov : |
|
Fizikalna stabilnost : |
|
Kemična stabilnost : |
|
Druge metode : |
|
Komentarji : |
|
Seznami
Naratriptan Hydrochloride
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
23°C |
|
7 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
23°C |
|
7 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
4°C |
|
90 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
4°C |
|
90 |
|
|
|
|
|